Day One Biopharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Day One Biopharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Day One Biopharmaceuticals Inc
Rating: 1.38165275
Author: Trendlyne DVM scores

Momentum Trap

about

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical devel...

9.45 -0.15 (-1.56%)

30.16% Fall from 52W High

847.1K

XNAS Volume

XNAS 26 Dec, 2025 4:30 PM (EST)

Low Financial Strength

11.1 / 100

Expensive Valuation

18.5 / 100

Technically Moderately Bullish

69.8 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 135%

8 analysts

Day One Biopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Day One Biopharma Inc Live Stock Price Today, Share Analysis and Chart

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical devel...

30.16% Fall from 52W High

SWOT Analysis

Day One Biopharma Inc Live Price Chart